Franklin Resources’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.5M Buy
1,034,154
+205,425
+25% +$17.2M 0.02% 475
2026
Q1
$66.4M Buy
828,729
+50,164
+6% +$4.14M 0.02% 558
2025
Q4
$66.4M Buy
778,565
+506,228
+186% +$41.5M 0.02% 549
2025
Q3
$21.2M Buy
272,337
+47,311
+21% +$3.7M 0.01% 932
2025
Q2
$17.6M Buy
225,026
+40,795
+22% +$3.04M ﹤0.01% 966
2025
Q1
$13.4M Sell
184,231
-967,478
-84% -$69.2M ﹤0.01% 1013
2024
Q4
$85.3M Sell
1,151,709
-44,350
-4% -$3.1M 0.02% 455
2024
Q3
$83.3M Buy
1,196,059
+27,193
+2% +$1.98M 0.02% 455
2024
Q2
$108M Sell
1,168,866
-16,555
-1% -$1.47M 0.03% 395
2024
Q1
$113M Buy
1,185,421
+58,749
+5% +$4.94M 0.04% 388
2023
Q4
$85.9M Sell
1,126,672
-170,150
-13% -$11.8M 0.04% 369
2023
Q3
$89.8M Sell
1,296,822
-458,565
-26% -$36.9M 0.05% 370
2023
Q2
$166M Sell
1,755,387
-31,521
-2% -$2.74M 0.08% 273
2023
Q1
$148M Sell
1,786,908
-807,106
-31% -$63.4M 0.07% 297
2022
Q4
$194M Sell
2,594,014
-1,104,141
-30% -$85.1M 0.1% 232
2022
Q3
$306M Sell
3,698,155
-177,113
-5% -$17M 0.17% 163
2022
Q2
$368M Sell
3,875,268
-374,035
-9% -$38.7M 0.18% 141
2022
Q1
$500M Buy
4,249,303
+80,476
+2% +$9.03M 0.2% 135
2021
Q4
$540M Buy
4,168,827
+107,260
+3% +$12.5M 0.19% 136
2021
Q3
$460M Buy
4,061,567
+53,357
+1% +$6.09M 0.17% 149
2021
Q2
$415M Buy
4,008,210
+2,879
+0.1% +$271K 0.16% 165
2021
Q1
$335M Sell
4,005,331
-206,543
-5% -$17.5M 0.14% 190
2020
Q4
$384M Sell
4,211,874
-196,927
-4% -$16.3M 0.16% 164
2020
Q3
$352M Sell
4,408,801
-51,370
-1% -$4.01M 0.17% 157
2020
Q2
$347M Sell
4,460,171
-95,293
-2% -$6.77M 0.18% 149
2020
Q1
$286M Sell
4,555,464
-31,755
-0.7% -$2.29M 0.19% 142
2019
Q4
$357M Sell
4,587,219
-31,968
-0.7% -$2.5M 0.19% 140
2019
Q3
$339M Buy
4,619,187
+144,612
+3% +$10.2M 0.18% 141
2019
Q2
$276M Sell
4,474,575
-167,088
-4% -$10.1M 0.15% 183
2019
Q1
$296M Sell
4,641,663
-1,207,545
-21% -$68.9M 0.16% 175
2018
Q4
$299M Sell
5,849,208
-108,300
-2% -$5.48M 0.18% 159
2018
Q3
$346M Sell
5,957,508
-170,775
-3% -$8.35M 0.17% 160
2018
Q2
$297M Buy
6,128,283
+1,416
+0% +$66.1K 0.15% 178
2018
Q1
$285M Sell
6,126,867
-492
-0% -$21.4K 0.14% 183
2017
Q4
$230M Sell
6,127,359
-251,319
-4% -$9.22M 0.11% 215
2017
Q3
$232M Sell
6,378,678
-6,474
-0.1% -$247K 0.11% 211
2017
Q2
$252M Sell
6,385,152
-68,469
-1% -$2.5M 0.13% 200
2017
Q1
$202M Sell
6,453,621
-1,544,592
-19% -$48.4M 0.1% 220
2016
Q4
$250M Sell
7,998,213
-1,028,670
-11% -$33.3M 0.13% 190
2016
Q3
$363M Sell
9,026,883
-447,771
-5% -$16.9M 0.19% 140
2016
Q2
$315M Sell
9,474,654
-15,840
-0.2% -$542K 0.17% 156
2016
Q1
$279M Buy
9,490,494
+1,076,616
+13% +$29.7M 0.15% 174
2015
Q4
$222M Buy
8,413,878
+20,274
+0.2% +$526K 0.11% 209
2015
Q3
$199M Buy
8,393,604
+2,493,984
+42% +$60.2M 0.1% 228
2015
Q2
$140M Buy
5,899,620
+248,880
+4% +$5.62M 0.06% 310
2015
Q1
$134M Buy
5,650,740
+1,806,720
+47% +$40.5M 0.06% 314
2014
Q4
$81.6M Sell
3,844,020
-2,400
-0.1% -$48.2K 0.04% 440
2014
Q3
$65.5M Sell
3,846,420
-8,400
-0.2% -$133K 0.03% 496
2014
Q2
$55.1M Buy
3,854,820
+577,200
+18% +$7.82M 0.02% 568
2014
Q1
$40.5M Buy
3,277,620
+24,780
+0.8% +$286K 0.02% 660
2013
Q4
$35.7M Sell
3,252,840
-373,200
-10% -$4.21M 0.02% 656
2013
Q3
$42.1M Sell
3,626,040
-24,000
-0.7% -$281K 0.02% 587
2013
Q2
$40.9M Buy
+3,650,040
New +$43.2M 0.02% 574

Other funds holding EW

Franklin Resources's EW Position: Q2 2026 in Review

Franklin Resources increased its Edwards Lifesciences (EW) stake by 25% in Q2 2026, buying an estimated $17.2M and bringing the position to 1,034,154 shares worth $93.5M. The position accounts for 0.02% of the portfolio, ranked #475.

Franklin Resources first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $540M in Q4 2021. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Franklin Resources held 1,034,154 shares of Edwards Lifesciences worth $93.5M as of Q2 2026.
  • Franklin Resources bought 205,425 Edwards Lifesciences shares in Q2 2026, an estimated $17.2M.
  • Edwards Lifesciences made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #475 holding.
  • Franklin Resources first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Franklin Resources's Edwards Lifesciences position peaked at $540M in Q4 2021.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.